Domov › Non-Hodgkinov lymfóm › Tennessee › Nashville
Klinické štúdie Non-Hodgkinov lymfóm v meste Nashville, TN
21 štúdií pre Non-Hodgkinov lymfóm hľadá účastníkov v zariadeniach v meste Nashville a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Prebieha náborFáza 1/2
- Tennessee Oncology, Pllc Nashville, Nashville
Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
Prebieha náborFáza 2
- Vanderbilt University/Ingram Cancer Center, Nashville
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Prebieha náborFáza 1/2
- SCRI Oncology Partners ( Site 0100), Nashville
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Prebieha náborFáza 2
- Tennessee Oncology - Nashville / Sarah Cannon Research Institute, Nashville
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Prebieha náborFáza 1
- SCRI Oncology Partners, Nashville
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Prebieha náborFáza 1
- Sarah Cannon Research Institute, Nashville
- Vanderbilt University Medical Center, Nashville
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Prebieha náborFáza 1
- Scri Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Prebieha náborFáza 2
- Research Site, Nashville
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Prebieha náborFáza 2
- Tennessee Oncology, Nashville
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
Prebieha náborFáza 1
- SCRI Oncology Partners, Nashville
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Prebieha náborFáza 1/2
- Research Site, Franklin · 17 míľ odtiaľ
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Prebieha náborFáza 1/2
- Vanderbilt University Medical Center, Nashville
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Prebieha náborFáza 3
- Sarah Cannon Research Institute SCRI, Nashville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Prebieha náborFáza 1/2
- TriStar BMT, Nashville
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Prebieha náborFáza 3
- SCRI Oncology Partners, Nashville
DALY II USA/ MB-CART2019.1 for DLBCL
Prebieha náborFáza 2
- SCRI Oncology Partners, Nashville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Prebieha náborObservačná štúdia
- Vanderbilt University, Nashville
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Prebieha náborFáza 4
- Tennessee Oncology, Nashville
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Prebieha náborFáza 4
- Tennessee Oncology, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Nashville
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Prebieha náborFáza 1/2
- SCRI Oncology Partners, Nashville
Štúdie Non-Hodgkinov lymfóm v iných mestách
- New York City, NY31 štúdií
- Houston, TX31 štúdií
- Boston, MA26 štúdií
- Philadelphia, PA20 štúdií
- Baldwin Park, CA19 štúdií
- Washington, DC18 štúdií
- Chicago, IL18 štúdií
- Atlanta, GA18 štúdií
- Milwaukee, WI18 štúdií
- Columbus, OH18 štúdií
- Dallas, TX17 štúdií
- Seattle, WA16 štúdií
Iné štúdie v Nashville
- Nemalobunkový karcinóm pľúc97 štúdií
- Rakovina prsníka81 štúdií
- Metastatická rakovina70 štúdií
- Kolorektálny karcinóm69 štúdií
- Rakovina (všetky typy)65 štúdií
- Rakovina vaječníkov49 štúdií
- Rakovina prostaty43 štúdií
- Rakovina pľúc40 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku39 štúdií
- Rakovina pankreasu39 štúdií
- Rakovina endometria38 štúdií
- Melanóm33 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.